查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1136946

EPA及DHA市场，各类型(二十碳五烯酸，二十二碳六烯酸)，供给来源，各用途，各地区- 规模，占有率，展望，机会分析，2022年～2030年

EPA and DHA Market, By Type (Eicosapentaenoic Acid, Docosahexaenoic Acid ), By Source, By Application, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场动态

对浓缩 omega-3 成分不断增长的需求正在显着推动 EPA 和 DHA 市场的增长。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球EPA及DHA市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球EPA及DHA市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球EPA及DHA市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球EPA及DHA市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称的说明

第2章 市场展望

  • 报告内容
    • 市场定义和范围
  • 摘要整理
    • 市场明细:各类型
    • 市场明细:各来源
    • 市场明细，各应用领域
    • 市场明细，各地区
  • 连贯机遇地图(COM)

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 由于健康意识的提高，对膳食补充剂的需求增加
    • 市场价格高
    • 主要参与者越来越关注探索 EPA 的提取过程
  • 影响分析
  • 主要的焦点
  • 法规方案
  • 产品的上市与核准
  • PEST分析
  • PORTER的分析
  • 合併·收购情景

第4章 EPA和DHA的全球市场:冠状病毒(COVID-19)疫情的影响

  • COVID-19流行病学的特征
  • 供给面和需求面分析
  • 经济影响

第5章 EPA和DHA的全球市场:各类型，2017年～2030年

  • 二十碳五烯酸(EPA)
  • 二十二碳六烯酸(DHA)

第6章 EPA和DHA的全球市场:不同供应商，2017年～2030年

  • 鱼油
  • 藻类油
  • 磷虾油
  • 其他的来源

第7章 EPA和DHA的全球市场:各用途，2017年～2030年

  • 婴幼儿配方奶粉
  • 营养补充品
  • 强化食品及食品和饮料
  • 医药品
  • 其他的用途

第8章 EPA和DHA的全球市场:各地区，2017年～2030年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲
  • 全球其他地区

第9章 竞争情形

  • Koninklijke DSM NV
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Clover Corporation Ltd
  • Croda International PLC
  • Others

第10章 章节

  • 调查手法的介绍
  • 关于出版社
简介目录
Product Code: CMI5200

EPA and DHA are fat-soluble omega-3 fatty acids that can be found in abundance in seafood, including fatty fish. They are also found in some grazed animal products. Although they are not the only source of EPA and DHA, they are essential for brain development. Research has indicated that EPA and DHA supplementation reduces the release of inflammatory factors, including IL-1B and granulocyte colony-stimulating factor. These findings indicate that EPA and DHA supplementation may be useful in preventing cognitive decline in people with mild to moderate Alzheimer's disease.

Market Dynamics:

Growing demand for concentrated form of omega-3 ingredients is predominantly fueling growth of the EPA and DHA market. Moreover, increasing demand for dietary supplements due to growing health awareness is again anticipated to foster market growth. Additionally, growing focus of key players to explore for extraction process for EPA is projected to provide significant growth opportunities over the forecast period. Furthermore, growing demand for vegan products and additives is gaining traction in the market.

On the Contrary, high market price is expected to hinder the market growth of EPA and DHA.

Key features of the study:

  • This report provides in-depth analysis of the global EPA and DHA market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global EPA and DHA market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

Detailed Segmentation:

  • Global EPA and DHA Market, By Type:
    • Eicosapentaenoic Acid (EPA)
    • Docosahexaenoic Acid (DHA)
  • Global EPA and DHA Market, By Source:
    • Fish Oil
    • Algae Oil
    • Krill Oil
    • Other Sources
  • Global EPA and DHA Market, By Application:
    • Infant Formulae
    • Dietary Supplements
    • Fortified Food and Beverages
    • Pharmaceuticals
    • Other Applications
  • Company Profiles
    • Koninklijke DSM NV*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • KD Pharma Group
    • The Archer Daniels Midland Company
    • Corbion NV
    • Novasep Holding SAS
    • Neptune Wellness Solutions
    • BASF SE
    • Clover Corporation Ltd
    • Croda International PLC
    • Novotech Nutraceuticals
    • Polaris

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing demand for dietary supplements due to growing health awareness
    • High market price
    • Growing focus of key players to explore for extraction process for EPA
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global EPA AND DHA Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global EPA AND DHA Market, By Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Eicosapentaenoic Acid (EPA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Docosahexaenoic Acid (DHA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global EPA AND DHA Market, By Source, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Fish Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Algae Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Krill Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Other Sources
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global EPA AND DHA Market, By Application, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Infant Formulae
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Fortified Food and Beverages
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Pharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global EPA AND DHA Market, By Region, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2017-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

9. Competitive Landscape

  • Koninklijke DSM NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KD Pharma Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • The Archer Daniels Midland Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Corbion NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novasep Holding SAS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Neptune Wellness Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Clover Corporation Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Croda International PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us